FOR some investors, most famously Warren Buffett (pic), it’s about the most important financial metric in judging corporate success – return on capital.
The recent failure of Unilever Plc’s £50bil (US$68bil or RM286bil) bid for GlaxoSmithKline (GSK) Plc’s consumer-healthcare business brings the concept into sharp relief.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!